Stay updated on Optimal Tenecteplase Dose in Stroke Clinical Trial
Sign up to get notified when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.

Latest updates to the Optimal Tenecteplase Dose in Stroke Clinical Trial page
- Check2 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check9 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the previous study details. This indicates the page is currently inaccessible and no trial information is visible.SummaryDifference18%

- Check51 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a recent software update to the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5 on the page, signaling a new build of the site. The update likely includes internal fixes or improvements without modifying displayed study details.SummaryDifference0.0%

- Check87 days agoChange DetectedThe page’s revision was updated from v3.6.3 to v3.6.4, reflecting a new release of the page software.SummaryDifference0.0%

Stay in the know with updates to Optimal Tenecteplase Dose in Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.